Rapid Medical Diagnostic Kits

Rapid Medical Diagnostic Kits Market Outlook

The global Rapid Medical Diagnostic Kits market was valued at approximately USD 24.5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of about 9.1% from 2025 to 2035. This growth can be attributed to the increasing prevalence of infectious diseases, the rising demand for rapid testing due to time-sensitive medical scenarios, and advancements in technology which enhance the speed and accuracy of diagnostics. Furthermore, the COVID-19 pandemic has significantly accelerated the adoption of rapid diagnostic kits, highlighting the need for immediate results in clinical and home settings. The growing trend of personalized medicine and self-testing is also anticipated to boost the market, allowing patients to monitor their health conditions conveniently.

Growth Factor of the Market

The rapid medical diagnostic kits market is experiencing robust growth driven primarily by technological advancements and the rising prevalence of chronic and infectious diseases. The fast-paced lifestyle of individuals has increased the demand for quick and efficient medical testing solutions, which in turn propels the growth of rapid diagnostic kits. Moreover, the rising awareness regarding preventive healthcare and the necessity for prompt diagnosis are key factors that are likely to drive market expansion. The growing aging population, which usually presents more health complications, further increases the demand for diagnostic testing. Additionally, the expansion of healthcare infrastructure and increasing healthcare expenditure in developing regions contribute to the overall growth of this market.

Key Highlights of the Market

• The market is expected to achieve a CAGR of 9.1% from 2025 to 2035.
• Technological advancements are enhancing the efficiency of rapid diagnostic kits.
• Increased healthcare expenditure and improved infrastructure are driving demand.
• Rising home care and self-testing segments are influencing market dynamics.
• The infectious disease kits segment holds the largest market share.

By Product Type

Infectious Disease Kits:

Infectious disease kits are among the most significant segments within the rapid medical diagnostic kits market. These kits are designed to provide fast and accurate results for various infectious diseases such as HIV, hepatitis, and COVID-19. The increasing incidence of infectious diseases globally, combined with the need for rapid testing, particularly during outbreaks and pandemics, has significantly contributed to the growth of this segment. The ability to conduct these tests in various settings, including hospitals, clinics, and even at home, enhances their accessibility and utility. Innovations in testing technology, such as the development of point-of-care testing solutions, are also playing a crucial role in expanding this segment's market share.

Cardiac Markers Kits:

Cardiac markers kits are essential for diagnosing and managing heart diseases. These kits are designed to detect specific proteins or enzymes released during a heart attack, enabling healthcare professionals to make timely decisions regarding patient care. The increasing prevalence of cardiovascular diseases, which are among the leading causes of death worldwide, has resulted in a rising demand for these rapid diagnostic kits. With advancements in technology, the accuracy and speed of results from cardiac markers kits have improved, leading to enhanced patient outcomes. Furthermore, the growing emphasis on preventive healthcare and early diagnosis propels the popularity of these kits in hospitals and clinics.

Pregnancy and Fertility Kits:

Pregnancy and fertility kits are specifically designed for home use, allowing women to detect pregnancy early and monitor their fertility cycles. The increasing awareness regarding reproductive health and family planning has boosted the demand for these kits. They provide a convenient solution for women to conduct tests in the privacy of their homes without needing to visit healthcare facilities. The rise in delayed pregnancies due to lifestyle changes and the growing focus on reproductive health are contributing factors to the expansion of this market segment. Additionally, advancements in testing technology have enhanced the accuracy and reliability of results, further solidifying their place in the market.

Cancer Markers Kits:

Cancer marker kits are gaining traction as they provide valuable information in the early detection and management of various cancers. These kits are crucial for identifying specific proteins or substances produced by cancer cells, enabling healthcare providers to initiate appropriate treatment plans swiftly. The increasing incidence of cancer worldwide, coupled with the rising awareness of early detection and personalized medicine, is driving the growth of this segment. Additionally, advancements in molecular diagnostics and biomarker discovery are contributing to the development of more effective cancer marker kits, enhancing their adoption across various healthcare settings.

Drugs of Abuse Kits:

Drugs of abuse kits are used for the rapid detection of illicit substances in various populations, including workplace testing, rehabilitation centers, and law enforcement. The growing concern over substance abuse and the need for effective monitoring solutions have driven the demand for these kits. Their ability to provide quick and accurate results is crucial in making urgent decisions related to treatment or legal action. The expansion of drug testing regulations in various sectors, including employment screenings and sports, further enhances the market for drugs of abuse kits. Innovations in test design and technology also contribute to increased specificity and sensitivity, making them more reliable.

By Application

Hospitals:

Hospitals are a primary application area for rapid medical diagnostic kits as they require immediate results to make prompt clinical decisions. The integration of these kits into hospital laboratories allows for fast turnaround times, which is essential in emergency scenarios. The increasing patient inflow and the need for efficiency in diagnosis drive the demand for rapid tests in hospital settings. Moreover, hospitals are increasingly adopting point-of-care testing processes that enable them to conduct tests at the bedside, thereby enhancing patient care and satisfaction. This trend is expected to continue driving the market for rapid diagnostic kits within hospitals significantly.

Clinics:

Clinics, particularly outpatient facilities, are also significant users of rapid medical diagnostic kits. These settings benefit from quick testing solutions that cater to various patient needs, facilitating the diagnosis of common ailments and chronic conditions. The demand for rapid tests in clinics is driven by the need for efficiency and cost-effectiveness in patient management. Patients seeking immediate answers to their health concerns prefer clinics that can provide rapid testing services, resulting in a positive client experience. As the trend towards decentralized healthcare continues, the demand for diagnostic kits in clinics is anticipated to grow.

Home Care Settings:

Home care settings have emerged as a vital application area for rapid medical diagnostic kits, particularly in the wake of the pandemic. Patients increasingly prefer the convenience of testing at home, driven by both health safety concerns and the desire for privacy. Rapid tests for various conditions, including pregnancy, diabetes, and infectious diseases, have become widely accessible through retail channels, allowing individuals to monitor their health conveniently. The growth of telemedicine and remote patient monitoring has further propelled the demand for home testing solutions, making this a significant and expanding segment of the market.

Diagnostic Laboratories:

Diagnostic laboratories are crucial in the rapid medical diagnostic kits market, as they play a key role in validating and processing diagnostic tests. These laboratories deploy rapid testing kits to provide timely results for various diseases, improving overall patient management and outcomes. The growing emphasis on laboratory efficiency and accuracy is driving the adoption of advanced rapid diagnostic tests in these settings. Additionally, the increasing complexity of tests and the need for high-throughput testing capabilities are encouraging laboratories to invest in innovative rapid diagnostics, thereby enhancing their role in the healthcare continuum.

By Distribution Channel

Online Stores:

Online stores have become a prominent distribution channel for rapid medical diagnostic kits due to the convenience they offer to consumers. The increasing penetration of the internet and smartphone usage has made it easier for consumers to access health products from the comfort of their homes. Online platforms provide a wide range of product options, allowing customers to compare prices and read reviews before making a purchase. The added benefit of discreet delivery also appeals to customers seeking privacy, especially for sensitive health issues. As e-commerce continues to grow, it is expected to further boost the sales of rapid diagnostic kits through online channels.

Pharmacies:

Pharmacies serve as a critical distribution channel for rapid medical diagnostic kits, providing easy access for consumers. Many individuals prefer to purchase diagnostic kits from local pharmacies, where they can receive immediate guidance from pharmacists regarding the products. The increasing number of pharmacies offering home healthcare products has contributed to the growth of this distribution channel. Furthermore, pharmacies often run promotional campaigns and offer discounts on rapid diagnostic kits, encouraging patients to utilize these products. As pharmacies expand their roles in healthcare delivery, their contribution to the rapid diagnostic kit market is expected to grow significantly.

Hospitals and Clinics:

Hospitals and clinics represent another key distribution channel for rapid medical diagnostic kits. These facilities often procure these kits in bulk to provide immediate testing for patients. The ability to offer rapid diagnostics enhances the service quality of hospitals and clinics, making them more attractive to patients seeking quick healthcare solutions. The procurement process is often facilitated by contracts with manufacturers or distributors, ensuring access to the latest testing technologies. The increasing focus on patient-centric care and the drive for improved healthcare delivery systems are likely to expand this distribution channel further.

Diagnostic Centers:

Diagnostic centers are specialized facilities that often utilize a wide range of rapid medical diagnostic kits to conduct tests for various diseases. These centers typically cater to patients seeking specific diagnostic evaluations and are known for their proficiency in testing. The demand for rapid tests in diagnostic centers is driven by the need for fast and accurate results, particularly for infectious diseases and chronic conditions. Moreover, the evolution of medical technology empowers diagnostic centers to offer a variety of testing options, increasing their reliance on rapid diagnostic kits. As the healthcare industry continues to focus on rapid testing solutions, the role of diagnostic centers in the market will likely expand.

Retail Stores:

Retail stores also play an essential role in the distribution of rapid medical diagnostic kits, making them readily available to consumers. The convenience of purchasing these kits in-store appeals to individuals who prefer immediate access to health products without the wait associated with online shopping. Retail chains increasingly stock a diverse range of diagnostic kits, catering to various health needs, including pregnancy tests, glucose monitoring, and infectious disease testing. In-store promotions and health awareness campaigns can further drive sales in this channel, as consumers are often encouraged to take charge of their health through accessible testing solutions.

By Test Type

Lateral Flow Assays:

Lateral flow assays are widely used in rapid medical diagnostic kits due to their simplicity and effectiveness in providing quick results. These tests operate on the principle of capillary action, allowing liquids to move through a test strip where the presence of a target analyte can be detected visually. Their ease of use and rapid turnaround time make them particularly suitable for point-of-care testing in various settings, including hospitals and home care. The ongoing advancements in lateral flow technology enhance sensitivity and specificity, resulting in more accurate diagnostics and contributing to the growth of this segment.

Agglutination Assays:

Agglutination assays are another important test type within the rapid medical diagnostic kits market. These tests rely on the agglutination reaction between antigens and antibodies to detect specific substances in a sample. Commonly used in blood typing and infectious disease testing, agglutination assays provide results rapidly, making them suitable for clinical settings. Their application in various diagnostic fields, combined with their cost-effectiveness, ensures their continued relevance in the market. As healthcare providers seek efficient testing methods, the demand for agglutination assays is expected to grow alongside advancements in immunology.

Immunofluorescence Assays:

Immunofluorescence assays utilize fluorescently labeled antibodies to detect specific antigens in specimens, providing a highly sensitive testing method. These assays are particularly useful in diagnosing autoimmune disorders and infectious diseases, where precision is critical. The ability to visualize the results through fluorescence microscopy allows for accurate interpretation, enhancing the reliability of diagnostics. The rising prevalence of autoimmune diseases and the need for accurate testing methods are driving the growth of this segment. Innovations in fluorescent labeling technology are expected to further enhance the efficacy and application scope of immunofluorescence assays.

Molecular Assays:

Molecular assays represent a sophisticated testing method that detects specific nucleic acid sequences, enabling the identification of pathogens at a genetic level. This test type is crucial in the rapid diagnosis of infectious diseases, including viral and bacterial infections, and plays a significant role in personalized medicine. The accuracy and speed of molecular assays make them particularly valuable in clinical settings, especially during disease outbreaks. The increasing need for precise diagnostics and targeted therapies is driving the adoption of molecular assays in rapid medical diagnostic kits. Ongoing research and development efforts in molecular biology are likely to enhance the capabilities and applications of these assays.

Solid Phase Assays:

Solid phase assays are employed in rapid medical diagnostic kits to detect specific proteins or other biomolecules by immobilizing them on a solid surface. These assays are valuable in various applications, including allergen testing and infectious disease diagnosis. Their ability to provide quantitative results alongside qualitative outcomes enhances their utility in clinical labs. The growing focus on biomarker discovery and the need for comprehensive diagnostic solutions are expected to drive the demand for solid phase assays significantly. Technological advancements in assay development are further improving sensitivity and specificity, making these tests increasingly relevant in the healthcare sector.

By Region

Regional analysis of the rapid medical diagnostic kits market reveals diverse trends and growth opportunities across different geographic areas. North America currently holds the largest market share, accounting for roughly 40% of the global market value, driven by advanced healthcare infrastructure, high awareness of healthcare products, and significant investments in R&D. The region is also witnessing a rapid increase in the adoption of home testing kits, particularly in light of the ongoing emphasis on preventive healthcare. The CAGR for North America is projected to be around 8.5%, reflecting steady growth due to the expansion of healthcare services and aging population requiring more diagnostic testing.

In contrast, the Asia Pacific region is expected to see the fastest growth during the forecast period, with a CAGR of approximately 10.5%. This growth can be attributed to the increasing prevalence of chronic diseases, expanding healthcare access, and rising disposable incomes in countries such as India and China. The region's commitment to improving healthcare infrastructure and the growing trend of self-testing are further propelling the demand for rapid medical diagnostic kits. As healthcare systems evolve, the Asia Pacific market is anticipated to witness significant advancements in the availability and effectiveness of diagnostic kits, aligning with global standards.

Opportunities

The rapid medical diagnostic kits market presents numerous opportunities driven by technological innovations and changing consumer preferences. One of the most significant opportunities lies in the development of point-of-care testing (POCT) solutions, which provide immediate results at the location of patient care. The demand for POCT is rising, particularly in resource-limited settings where access to traditional laboratory testing may be challenging. Companies that focus on creating portable, user-friendly testing kits that cater to the POCT segment stand to gain a competitive advantage. Additionally, the increasing focus on preventive healthcare and early diagnosis presents lucrative opportunities for manufacturers to innovate and introduce new products into the market.

Furthermore, partnerships and collaborations with healthcare providers can enhance market presence and product accessibility. Companies that engage in strategic alliances with hospitals, clinics, and pharmacies are better positioned to understand market needs and tailor their offerings accordingly. The integration of digital technology, including telemedicine and remote monitoring, into rapid diagnostic solutions also presents significant growth potential. By exploring these avenues, stakeholders can capitalize on the evolving landscape of healthcare and the growing recognition of the importance of rapid diagnostics in managing public health effectively.

Threats

While the market for rapid medical diagnostic kits is expanding, it is not without its challenges and threats. One of the primary threats to the market is the emergence of counterfeit and low-quality products, which can undermine consumer confidence in rapid diagnostic tests. As demand grows, the risk of non-compliant products entering the market increases, posing serious health risks to patients and adversely affecting the reputation of established brands. Regulatory challenges, including stringent approval processes for new diagnostic kits, can also impede market growth. Companies must navigate complex regulatory landscapes, which may vary by region, to ensure their products meet safety and efficacy standards.

Moreover, the rapid evolution of technology poses a constant threat in terms of competition. New entrants and established companies alike are continuously innovating, leading to a highly competitive landscape. The rapid pace of technological change means that existing products may quickly become outdated, requiring companies to invest heavily in R&D to stay relevant. Additionally, fluctuations in healthcare budgets and potential economic downturns can impact the funding for diagnostic services, potentially leading to reduced demand for rapid medical diagnostic kits. Stakeholders must remain vigilant and adaptable to navigate these threats effectively.

Competitor Outlook

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Quidel Corporation
• Alere Inc.
• OraSure Technologies
• Cepheid
• Hologic, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Grifols S.A.
• GenMark Diagnostics, Inc.
• ThermoFisher Scientific

The competitive landscape of the rapid medical diagnostic kits market is characterized by the presence of both established players and emerging companies. Major companies like Abbott Laboratories and Roche Diagnostics dominate the market due to their extensive product portfolios and robust research and development capabilities. These companies are continually innovating to introduce advanced rapid diagnostic solutions, thereby enhancing their competitive edge. The increasing focus on point-of-care testing and home diagnostics has prompted these organizations to invest heavily in new product development, ensuring they meet the evolving needs of healthcare providers and consumers alike.

In addition to established companies, several emerging players are also making a significant impact on the market. Companies like Quidel Corporation and OraSure Technologies are focusing on niche segments within rapid diagnostics, leading to increased competition. These companies often prioritize agility and innovation, allowing them to respond quickly to market changes and consumer preferences. Strategic partnerships, mergers, and acquisitions are common in this sector, as companies seek to expand their reach and enhance their product offerings. The dynamic nature of the rapid medical diagnostic kits market ensures that competition remains fierce, driving continuous improvements and technological advancements.

Key players such as Siemens Healthineers and Thermo Fisher Scientific are also noteworthy for their commitment to enhancing diagnostic accuracy and efficiency. Siemens Healthineers, for example, has been at the forefront of developing innovative diagnostic solutions that leverage artificial intelligence and automation to streamline testing processes. Thermo Fisher Scientific, on the other hand, focuses on expanding its molecular diagnostics portfolio, capitalizing on the growing demand for precise and rapid testing solutions. As these companies continue to innovate, the competitive landscape will evolve, presenting both challenges and opportunities for stakeholders within the rapid medical diagnostic kits market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cepheid
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Alere Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Grifols S.A.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Hologic, Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Roche Diagnostics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Quidel Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Abbott Laboratories
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Danaher Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 OraSure Technologies
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Siemens Healthineers
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 ThermoFisher Scientific
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Thermo Fisher Scientific
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 GenMark Diagnostics, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Bio-Rad Laboratories, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Rapid Medical Diagnostic Kits Market, By Test Type
    • 6.1.1 Lateral Flow Assays
    • 6.1.2 Agglutination Assays
    • 6.1.3 Immunofluorescence Assays
    • 6.1.4 Molecular Assays
    • 6.1.5 Solid Phase Assays
  • 6.2 Rapid Medical Diagnostic Kits Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Home Care Settings
    • 6.2.4 Diagnostic Laboratories
  • 6.3 Rapid Medical Diagnostic Kits Market, By Product Type
    • 6.3.1 Infectious Disease Kits
    • 6.3.2 Cardiac Markers Kits
    • 6.3.3 Pregnancy and Fertility Kits
    • 6.3.4 Cancer Markers Kits
    • 6.3.5 Drugs of Abuse Kits
  • 6.4 Rapid Medical Diagnostic Kits Market, By Distribution Channel
    • 6.4.1 Online Stores
    • 6.4.2 Pharmacies
    • 6.4.3 Hospitals and Clinics
    • 6.4.4 Diagnostic Centers
    • 6.4.5 Retail Stores

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Rapid Medical Diagnostic Kits Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Rapid Medical Diagnostic Kits market is categorized based on

By Product Type

• Infectious Disease Kits
• Cardiac Markers Kits
• Pregnancy and Fertility Kits
• Cancer Markers Kits
• Drugs of Abuse Kits

By Application

• Hospitals
• Clinics
• Home Care Settings
• Diagnostic Laboratories

By Distribution Channel

• Online Stores
• Pharmacies
• Hospitals and Clinics
• Diagnostic Centers
• Retail Stores

By Test Type

• Lateral Flow Assays
• Agglutination Assays
• Immunofluorescence Assays
• Molecular Assays
• Solid Phase Assays

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthineers
• Thermo Fisher Scientific
• BD (Becton, Dickinson and Company)
• Quidel Corporation
• Alere Inc.
• OraSure Technologies
• Cepheid
• Hologic, Inc.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Grifols S.A.
• GenMark Diagnostics, Inc.
• ThermoFisher Scientific